ACC 2014 Roundup: Study shows long-term benefits for some CRT-D patients

Seven-year results from Boston Scientific's MADIT-CRT trial show long-term benefits for some patients with mild heart failure.

Some patients with mild heart failure show significant, long-term benefits from cardiac-resynchronization therapy, according to the 7-year results from Boston Scientific's (NYSE:BSX) MADIT-CRT clinical trial presented at the American College of Cardiology's annual meeting over the weekend.

American College of Cardiology, Boston Scientific, Abbott Laboratories

News Well, Clinical Trials, ACC 2014, Bariatrics, Diabetes, Replacement Heart Valves, Stent Wars

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1oiHlOz